# 🧠 Methodology & AI Collaboration Report
**Project Phase:** Phase 3: Exploratory Data Analysis (EDA) Refinement
**Author:** KHAWLA BENNACEUR
**Document Purpose:** To document the architectural decisions, domain-specific logic validation, and advanced prompt-engineering collaboration used to build the clinical and financial data models.

---

## 📋 Table of Contents
1. Core Architectural Strategy (File Decoupling)
2. Clinical Logic Validation & Refactoring
3. Synthetic Data Discrepancies & Resolutions
4. AI Collaboration Blueprint (Human-in-the-Loop)
5. Impact on Downstream Reporting (Power BI Preparation)

---

## 1. Core Architectural Strategy (File Decoupling)
* **The Initial State:** The project phase began with a single planned EDA file (`03_clinical_financial_eda.sql`).
* **The Strategic Shift:** To optimize data granularity, prevent visual noise, and implement engineering best practices, the analysis was decoupled into two specialized domain files:
  * `03_clinical_analytics_eda.sql`: Focused on patient risk stratification, treatment velocity, and operational capacity.
  * `04_financial_analytics_eda.sql`: Focused on insurance revenue cycles, billing variances, and hospital cost-per-day metrics.

## 2. Clinical Logic Validation & Refactoring
*This section highlights my analytical pushback and refusal to accept generic data structures.*

* **The Challenge:** Initial automated baselines attempted to classify clinical risk by blending diagnostic outcomes and medication fields into a single high-granularity matrix. This caused severe data dilution (too many rows per case) and included arbitrary restrictions (e.g., limiting symptomatic care profiles to only infections and injuries).
* **The Critical Analysis:** I identified that any medical condition (such as chronic diabetes or acute respiratory failure) could present a "Normal" baseline lab entry snapshot at admission while still requiring urgent symptomatic care or preventative pathways.
* **The Engineering Resolution:** I overrode the initial structure to develop a **Universal Clinical Profiling Matrix** using a windowed CTE framework:
  ```sql
  CASE 
      WHEN test_results = 'Abnormal' AND length_of_stay > 7 THEN 'Acute / Severe Case'
      WHEN test_results = 'Abnormal' AND length_of_stay <= 7 THEN 'Acute / Well-Managed Case'
      WHEN test_results = 'Normal' AND length_of_stay <= 3 THEN 'Symptomatic / Acute Preventative Care'
      ELSE 'Routine Management / Stable Chronic'
  END AS clinical_profile
  ```

## 3. Synthetic Data Discrepancies & Resolutions
* **The Nature of the Data:** Acknowledgment that the source dataset utilizes synthetic generative patterns, which can introduce clinical anomalies (such as "Infections" presenting completely normal test results).
* **Analytical Treatment:** Rather than altering raw values or forcing unnatural medical rules, the anomalies were contextualized operationally. Normal-testing acute entries are strategically mapped as localized or early-stage outpatient pathways, transforming a dataset limitation into a sophisticated data-stratification feature.

## 4. AI Collaboration Blueprint (Human-in-the-Loop)
* **Scaffolding vs. Architecture:** AI was leveraged as an accelerated execution partner to quickly scaffold raw syntax structures, aggregate functions, and windowing configurations (`OVER (PARTITION BY...)`).
* **The Human-in-the-Loop Safeguard:** I served as the primary system architect and domain expert—rigorously reviewing every query for business logic alignment, diagnosing `ONLY_FULL_GROUP_BY` SQL mode violations, and forcing code iterations until the data boundaries were bulletproof.

## 5. Impact on Downstream Reporting (Power BI Preparation)
* **Granularity Control:** By separating macro risk trends from micro medication performance metrics into two clean SQL views, the backend logic dramatically simplifies dashboard filter actions (slicers).
* **Dashboard Readiness:** The resulting output yields clean, predictable categorical dimensions, preventing visual clutter in Power BI matrix visuals and ensuring an indisputable, logical data narrative for stakeholders.

## 6. Financial Logic Validation & Revenue Refactoring
-- Ongoing...